Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Y Lee

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Optics Express|July 14, 2016
Error-free operation of a polarization-insensitive 4λ x 25 Gbps silicon photonic WDM receiver with closed-loop thermal stabilization of Si microringsDaniel Y Lee, Xuezhe Zheng, Jin Yao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2023
Subsets of IFN Signaling Predict Response to Immune Checkpoint Blockade in Patients with MelanomaBrooke Horowitch, Daniel Y Lee, Min Ding, et al.
Journal of Pharmaceutical Sciences|July 2, 2009
Oral sulfasalazine as a clinical BCRP probe substrate: pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministrationKimberly K Adkison, Soniya S Vaidya, Daniel Y Lee, et al.
Optics Express|September 24, 2016
Efficient, tunable flip-chip-integrated III-V/Si hybrid external-cavity laser arrayShiyun Lin, Xuezhe Zheng, Jin Yao, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2004
A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticlesLingyun Li, Charles A Wartchow, S Narasimhan Danthi, et al.
Cancer Research|May 3, 2014
Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancerMan-Li Luo, Chang Gong, Chun-Hau Chen, et al.
Bioconjugate Chemistry|January 28, 2010
Synthesis and evaluation of a near-infrared fluorescent non-peptidic bivalent integrin alpha(v)beta(3) antagonist for cancer imagingFeng Li, Jiacheng Liu, Gouri S Jas, et al.
Plos One|September 7, 2012
Ergosterol peroxide isolated from Ganoderma lucidum abolishes microRNA miR-378-mediated tumor cells on chemoresistanceQing-Ping Wu, Yi-Zhen Xie, Zhaoqun Deng, et al.
Clinical and Translational Radiation Oncology|January 31, 2023
Salvage radiotherapy for relapsed/refractory non-Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapyNikhil Yegya-Raman, Christopher M Wright, Michael J LaRiviere, et al.
Oral Oncology|September 2, 2021
Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgeryChristopher M Wright, Daniel Y Lee, David Shimunov, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Optics Express|July 14, 2016
Error-free operation of a polarization-insensitive 4λ x 25 Gbps silicon photonic WDM receiver with closed-loop thermal stabilization of Si microringsDaniel Y Lee, Xuezhe Zheng, Jin Yao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2023
Subsets of IFN Signaling Predict Response to Immune Checkpoint Blockade in Patients with MelanomaBrooke Horowitch, Daniel Y Lee, Min Ding, et al.
Journal of Pharmaceutical Sciences|July 2, 2009
Oral sulfasalazine as a clinical BCRP probe substrate: pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministrationKimberly K Adkison, Soniya S Vaidya, Daniel Y Lee, et al.
Optics Express|September 24, 2016
Efficient, tunable flip-chip-integrated III-V/Si hybrid external-cavity laser arrayShiyun Lin, Xuezhe Zheng, Jin Yao, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2004
A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticlesLingyun Li, Charles A Wartchow, S Narasimhan Danthi, et al.
Cancer Research|May 3, 2014
Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancerMan-Li Luo, Chang Gong, Chun-Hau Chen, et al.
Bioconjugate Chemistry|January 28, 2010
Synthesis and evaluation of a near-infrared fluorescent non-peptidic bivalent integrin alpha(v)beta(3) antagonist for cancer imagingFeng Li, Jiacheng Liu, Gouri S Jas, et al.
Plos One|September 7, 2012
Ergosterol peroxide isolated from Ganoderma lucidum abolishes microRNA miR-378-mediated tumor cells on chemoresistanceQing-Ping Wu, Yi-Zhen Xie, Zhaoqun Deng, et al.
Clinical and Translational Radiation Oncology|January 31, 2023
Salvage radiotherapy for relapsed/refractory non-Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapyNikhil Yegya-Raman, Christopher M Wright, Michael J LaRiviere, et al.
Oral Oncology|September 2, 2021
Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgeryChristopher M Wright, Daniel Y Lee, David Shimunov, et al.
Pageof 7